CSIMarket
 




Us-china Biomedical Technology, Inc.  (CLDS)
Other Ticker:  
 
    Sector  Services    Industry Advertising
   Industry Advertising
   Sector  Services
 



CLDS Price to Earnings Ratio (Feb 28 2018) (Nov 30 2017) (Aug 31 2017) (May 31 2017)
Diluted EPS 12 Trailing Months IV. Quarter III. Quarter II. Quarter I. Quarter
PE (TTM) Ratio current            -            -            -            -            -
Diluted EPS TTM Y / Y Change - % - % - % - % - %
Diluted EPS Y / Y Change - % - % - % - % - %
Stock performance to date 8855.81 % -81.3 % 59 %

Price to earnings ratio Comment
Us-china Biomedical Technology, Inc.'s recorded net loss in trailing twelve months.

Within Services sector 2 other companies have lower Price to earnings ratio.

What is Price to Earnings Ratio?
What is Us-china Biomedical Technology, Inc. Market Share?

Price to earnings ratio Company Ranking
Within: No.
Industry #0
Sector #3
S&P 500 #36







Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com